Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Senior Editor
UK
6+ years of experience
HBW Insight
By David Ridley 13 Sep 2021
Amazon is becoming an increasingly important retail channel for the German wellness market. An analysis of best-selling categories, Omega 3, vitamin B and probiotic supplements, by Sempora Consulting suggests a mixture of exclusive and hybrid selling strategies can deliver results.
HBW Insight
By David Ridley 05 Jul 2021
“We are actively researching how to be the first OTC pharmaceutical firm to have a blister strip that satisfies regulations that is also recyclable,” reveals Perrigo's sustainability chief Steve Ramus in an exclusive interview with HBW Insight. Ramus also talks about the importance of being genuine when approaching ESG strategy.
HBW Insight
By David Ridley 05 May 2021
As Germany remains in lockdown, sales in its OTC market struggle to return to pre-pandemic levels, according to new data from Sempora Consulting. Meanwhile, COVID-related trends for wellness and online shopping endure, indicating some strategic priorities for OTC firms operating in the country.
HBW Insight
By David Ridley 23 Mar 2021
More EU countries than you might think allow the terms "prebiotic" and "probiotic" on food supplement labels, suggests a survey from consultancy firm Sandwalk Bioventures. HBW Insight speaks to Sandwalk's managing director, Luis Gosalbez, about a possible move towards liberalization in the region among member states, as well as a way forward for EU regulators lagging behind this localized movement.
HBW Insight
By David Ridley 08 Dec 2020
Europe’s self-care industry has “learned its lessons,” particularly in terms of securing the pharmaceutical ingredient supply chain, and will come out of the coronavirus pandemic stronger, insisted AESGP president Birgit Schuhbauer at the BAH’s High-Level Conference on Future Drug Supply in the European Union.
Topic EU OTC Drugs Coronavirus
HBW Insight
By David Ridley 29 Nov 2020
Will the second wave of coronavirus lockdown have the same impact on the European consumer health industry? Speaking exclusively to HBW Insight from Germany, Merz Consumer Care CEO Frank Baldauf thinks not. Recently investing in premium beard care brand Brooklyn Soap and launching its tetesept Formula range in the Netherlands, Merz's Baldauf suggest that there will be less panic buying this time round and the CHC supply chain will hold up under pressure.
Topic Coronavirus OTC Drugs EU
HBW Insight
By David Ridley 15 Jul 2020
UK's NICE reviews whether Vitamin D can prevent or treat COVID-19, finds evidence wanting.
HBW Insight
By David Ridley 14 May 2020
Australia looks at switching CBD as an OTC medicine, CBDepot becomes the first European firm with an EU Novel Food validation and the UK's Vitality CBD gets a boost from the global, coronavirus-driven wellness trend.
HBW Insight
By David Ridley 31 Mar 2020
Feature: Public Health England has revealed it is only a week away from approving a COVID-19 antibody test for distribution via Amazon. HBW Insight looks at the race to place the first, government-approved coronavirus home-test on the UK market.
Topic Coronavirus
HBW Insight
By David Ridley 19 Mar 2020
In response to the outbreak of the Covid-19 pandemic in Europe, the region's self-care industry is working hard to keep shelves stocked with crucial OTC medicines and food supplements, according to the AESGP.
Topic Coronavirus
HBW Insight
By David Ridley 29 Jan 2020
CBD products already on the UK market are safe for now, as the country's Food Standards Agency says it will not take action while it works out how to implement the new European Union novel food regulations.
HBW Insight
By David Ridley 18 Dec 2019
Reckitt Benckiser wants to give British parents more pain relief options for their teens and "tweens."
HBW Insight
By David Ridley 13 Nov 2019
Following a landmark win against the German government for the Rx-to-OTC switch of desloratadine last month, Novartis has again secured a victory in the German Higher Court system, this time to continue marketing its Biosan probiotics range in the country.
HBW Insight
By David Ridley 07 Aug 2019
Japan's new Rx-to-OTC switch procedure has exacerbated a "switch lag" compared with developed countries, says Japan Self-Medication Industry senior adviser Toshi Tominaga in an exclusive interview with HBW Insight. Tominaga proposes improvements such as self-care education for consumers and drug usage advice included by firms in switch applications to help balance the risk-benefit decisions of expert judges.
Topic Policy & Regulation
HBW Insight
By David Ridley 05 Jul 2019
The UK's cannabidiol market, which according to the Cannabis Trades Association is the largest in Europe, awaits clarification on the legal status of CBD-containing food supplements. Meanwhile, major retailers like Walgreen Boots Alliance are stepping into the space with branded products.
Generics Bulletin
25 Jul 2022
Generics Bulletin
25 Jul 2022
HBW Insight
07 Jul 2022
HBW Insight
06 Jul 2022
HBW Insight
01 Jul 2022
HBW Insight
30 Jun 2022
HBW Insight
22 Jun 2022
HBW Insight
21 Jun 2022
HBW Insight
17 Jun 2022
HBW Insight
15 Jun 2022
HBW Insight
15 Jun 2022
HBW Insight
10 Jun 2022
HBW Insight
10 Jun 2022
HBW Insight
03 Jun 2022
HBW Insight
30 May 2022
